On Friday, Gilead Sciences, Inc. (GILD) stock saw a modest uptick, ending the day at $92.46 which represents a slight increase of $0.05 or 0.05% from the prior close of $92.41. The stock opened at $92 ...
The drug has been called a profound advancement in medicine but getting it to those who need it is a "missing piece in the ...
On the occasion of the 37th World AIDS Day, the Chinese Association of STD and AIDS Prevention and Control and China Youth ...
The Tampa Bay Times e-Newspaper is a digital replica of the printed paper seven days a week that is available to read on ...
I'm sometimes asked how I started in AIDS organizing. Although it’s hard to pin when it happened, I will always remember ...
Aids was first identified 40 years ago: these are the game changers that have revolutionised treatment – and the obstacles ...
The twice-yearly HIV prevention shot from Gilead Sciences has proven 100% effective in women and nearly as effective in men, ...
South Africa is a good example of a country that would benefit from the discovery of a cure. South Africa’s been providing ...
Hosted on MSN2d
Gilead Stock Surges 44.2% in 6 Months: Time to Buy or Sell?Biotech giant Gilead Sciences, Inc.’s GILD shares have risen 44.2% in the past six months compared with the industry’s growth of 1.1%. The stock has also outperformed the sector and the S&P 500. It ...
On Wednesday, Gilead Sciences, Inc. (GILD) stock saw a modest uptick, ending the day at $92.41 which represents a slight increase of $1.06 or 1.16% from the prior close of $91.35. The stock opened at ...
As breakthroughs in biotechnology accelerate, the sector is primed for significant expansion. With emerging trends like gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback